Logo - springer
Slogan - springer

Chemistry | Alzheimer's Disease

Alzheimer's Disease

With contributions by numerous experts

Bradbury, Rob, Brodney, Michael A. (Eds.)

2008, XIII, 179 p.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$219.00

(net) price for USA

ISBN 978-3-540-74229-6

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$279.00

(net) price for USA

ISBN 978-3-540-74228-9

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$279.00

(net) price for USA

ISBN 978-3-642-09354-8

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • An overview chapter introduces the newcomer to the topic covered
  • Part of a series that covers hot topics of frontier research summarized by reputed scientists in the field
  • Review series is topic related
  • Online version available on SpringerLink: springerlink.com

Alzheimer’s disease (AD) is a neurodegenerative disease that robs the minds of our elderly population. Approximately one in every eight adults over the age of 65 and nearly half of those over 85 are afflicted with this disease. The aging population in developed societies will impose an ever increasing socioeconomic threat in the future. Current medicines for AD patients are mainly symptomatic treatments and a huge medical need exists to slow the progression of this disease.

A great deal of research has been dedicated to understanding the pathogenesis of AD from which comes many ideas for intervening with its progression. Some of these ideas have been fast-tracked to clinical trials due to the availability of medicines with proven clinical efficacies for other diseases while others represent novel chemical entities.

This volume will first review existing cholinesterase inhibitors prescribed for AD patients followed by some target mechanisms with ongoing clinical trials. It offers a glimpse of what our future medicine cabinets may look like for AD patients. It also provides an interesting read on why and how current medicines for other indications could po

Content Level » Research

Keywords » Alzheimer - Medicinal Chemistry - Molecular Chemistry - Organic Chemistry - Pharmaceutical Chemistry - Pharmacy

Related subjects » Chemistry - Molecular Medicine - Organic Chemistry - Pharmacology & Toxicology

Table of contents 

Therapeutic Approaches for the Treatment of Alzheimer's Disease: An Overview.- Cholinesterase Inhibitors.- Beyond Cholesterol: Statin Benefits in Alzheimer's Disease.- PPAR? Agonists for the Treatment of Alzheimer's Disease.- Metal Complexing Agents for the Treatment of Alzheimer's Disease.- GSK-3 Inhibitors for the Treatment of Alzheimer's Disease.

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Medicinal Chemistry.